Search Results - "Mottola, Leonardo"
-
1
Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial
Published in Hepatology (Baltimore, Md.) (01-01-2008)“…It was hypothesized that in hepatitis C virus (HCV) genotype 1 patients, variable treatment duration individualized by first undetectable HCV RNA is as…”
Get full text
Journal Article -
2
Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experience
Published in PloS one (23-10-2014)“…Triple therapy including Telaprevir or Boceprevir still represents in many European countries the standard of care for patients with Hepatitis C Virus genotype…”
Get full text
Journal Article -
3
-
4
What's new in HCV genotype 2 treatment
Published in Liver international (01-02-2012)“…Genotype 2 (HCV‐2) accounts for 8% of the patients with chronic hepatitis C virus in Europe. Because of the favourable response to interferon (IFN)‐based…”
Get full text
Journal Article -
5
Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients
Published in World journal of gastroenterology : WJG (21-12-2013)“…Single nucleotide polymorphisms near the interleukin 28B (IL-28B) gene have been identified as strong predictors of both spontaneous or Peg-interferon…”
Get full text
Journal Article -
6
An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response
Published in Gastroenterology (New York, N.Y. 1943) (01-09-2010)“…Background & Aims Polymorphisms in the region of the interleukin (IL)-28B gene on chromosome 19 have been associated with peginterferon-alfa–induced clearance…”
Get full text
Journal Article -
7
Treatment of Non-Genotype 1 Hepatitis C Virus Patients
Published in Current gastroenterology reports (01-02-2012)“…The HCV genotype will remain an important, independent pre-treatment predictor of virological response. While direct acting antivirals (DAA) will improve in…”
Get full text
Journal Article -
8
Limited use of interleukin 28B in the setting of response‐guided treatment with detailed on‐treatment virological monitoring
Published in Hepatology (Baltimore, Md.) (02-09-2011)“…A single‐nucleotide polymorphism upstream of the interleukin‐28B (IL28B) gene is associated with pegylated interferon‐alfa–induced viral clearance in hepatitis…”
Get full text
Journal Article -
9
Update on the Treatment of Patients With Non—Genotype 1 Hepatitis C Virus Infection
Published in Clinical infectious diseases (01-05-2013)“…Current treatment for patients with non—genotype 1 hepatitis C virus infection consists of pegylated interferon plus ribavirin for 24 weeks, which leads to…”
Get full text
Journal Article -
10
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR
Published in Hepatology (Baltimore, Md.) (01-02-2011)“…Two functional variants in the inosine triphosphatase (ITPA) gene causing inosine triphosphatase (ITPase) deficiency protect against ribavirin (RBV)‐induced…”
Get full text
Journal Article -
11
Treatment optimization and prediction of HCV clearance in patients with acute HCV infection
Published in Journal of hepatology (01-08-2013)“…Background & Aims The lack of consensus on the optimal timing, regimen, and duration of treatment, in patients with acute HCV infection, stimulates the…”
Get full text
Journal Article -
12
Sa1026 Liposome-Encapsulated Silybin and Hepatitis C Virus Infection
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2013)Get full text
Journal Article -
13
Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3
Published in Journal of hepatology (01-12-2010)“…Background & Aims The benefit of individualizing treatment for patients with genotype 3 HCV infection on the basis of viral clearance at week 4 (wk4-R) has not…”
Get full text
Journal Article -
14
Interleukin-28B genetic variants in untreated Italian HCV-infected patients: a multicentre study
Published in Liver international (01-02-2015)“…Background & Aims Different prevalence of favourable IL28BCC genotype have been reported in studies performed in different countries around the world. Data on…”
Get full text
Journal Article -
15
IL28B CC-genotype association with HLA-DQB10301 allele increases the prediction of spontaneous HCV RNA clearance in thalassaemic HCV-infected patients
Published in Antiviral therapy (01-01-2011)“…A single nucleotide polymorphism (SNP), upstream of the IL28B gene has been recently associated with natural clearance of HCV. In a well-characterized cohort…”
Get more information
Journal Article -
16
RIBAVIRN DOSAGE IN HCV GENOTYPES 2 AND 3 PATIENTS COMPLETING SHORT THERAPY WITH PEG-INTERFERON ALFA-2B AND RIBAVIRIN
Published in Alimentary pharmacology & therapeutics (08-03-2010)“…Background. Optimal dose of ribavirin to be used in combination with Peg-IFN in HCV genotype 2/3 patients undergoing short treatment has not been established…”
Get full text
Journal Article -
17
Influence of whole-body vibration static exercise on quadriceps oxygenation
Published in Advances in experimental medicine and biology (2006)Get more information
Journal Article -
18
Principles, techniques, and limitations of near infrared spectroscopy
Published in Canadian journal of applied physiology (01-08-2004)“…In the last decade the study of the human brain and muscle energetics underwent a radical change, thanks to the progressive introduction of noninvasive…”
Get more information
Journal Article -
19
Vastus lateralis metabolic response to explosive maximal isometric leg press exercise
Published in Advances in experimental medicine and biology (2006)Get more information
Journal Article